Myung In Pharmaceutical LTD. (KRX:317450)
South Korea · Delayed Price · Currency is KRW 56,700
+500 (0.89%)
At close: Apr 29, 2026
KRX:317450 Market Cap
KRX:317450 has a market cap or net worth of 820.52 billion as of April 29, 2026.
Market Cap
820.52B
Enterprise Value
312.21B
Revenue
287.25B
Ranking
n/a
PE Ratio
8.37
Stock Price
56,700.00
Market Cap Chart
Since October 1, 2025, KRX:317450's market cap has decreased from 1.78T to 820.52B, a decrease of -53.90%. That is a compound annual growth rate of -73.97%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 29, 2026 | 826.36B | -17.85% |
| Dec 30, 2025 | 1.01T | -43.48% |
| Oct 1, 2025 | 1.78T | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| G2GBIO | 1.31T |
| Samyang Biopharm | 582.97B |
| ImmuneOncia Therapeutics | 528.73B |
| CellBion | 483.75B |
| HEM Pharma | 426.98B |
| DAE HWA Pharmaceutical | 262.92B |
| NOVAREX | 258.45B |
| GREEN CROSS WellBeing | 246.48B |